“A Randomized Vehicle-Controlled Trial to Assess the Efficacy, Safety, and Tolerability of Ozenoxacin 1% Cream in 412 Patients 2 Months and Older with Impetigo” (2017) SKIN The Journal of Cutaneous Medicine, 1(3.1), p. s103. doi:10.25251/skin.1.supp.102.